Literature DB >> 8627603

Mapping the melatonin receptor. 4. Comparison of the binding affinities of a series of substituted phenylalkyl amides.

P J Garratt1, S Travard, S Vonhoff, A Tsotinis, D Sugden.   

Abstract

A series of 2-, 3-, and 4-substituted phenylalkyl amides were prepared as potential melatonin analogs in order to investigate the nature of the binding site of the melatonin receptor in chicken brain. The length of the alkyl chain was systematically varied from n = 1 to 4, and methoxyl substituents were incorporated into the phenyl ring at the 2-, 3-, and 4-positions. The maximum binding affinity was found to occur when n = 3 and when the methoxyl substituent was in the 3-position, the direct analog of the carbon framework of melatonin in which the 1,2-atoms of the indole ring have been removed. Whereas there was only a relatively small decrease in binding affinity for the corresponding 2-methoxy derivatives, 4-methoxyl substitution led to a large decrease in binding affinity, suggesting that the binding sites for the side chain and methoxyl group could not now be occupied at the same time. As in the indole analogs of melatonin, replacement of the methyl group of the amide by a longer alkyl chain led to an increase in binding affinity for ethyl and propyl with a subsequent decrease in binding affinity for butyl chains. Thus N-propanoyl-3-(3-methoxyphenyl)propanamine (6f) has a binding affinity of 5.6 nM, a remarkably high affinity for so simple a compound. Substitution of halogen for 3-methoxyl in the propanamide series gave a series of compounds with lower, but still substantial, binding affinities, the 3-chloro derivative 7e showing the highest affinity, 113 nM. In the case of the 3-fluoro propanamides, a maximum in the binding affinity was not observed in the series synthesized, and these derivatives will merit further exploration. These results demonstrate the utility of simple, readily modified phenylalkylamines as a "framework" for studying the effect of changes in the nature and position of substituents on the melatonin receptor binding affinity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627603     DOI: 10.1021/jm9508189

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

1.  Molecular modeling study of the mechanism of ligand binding to human melatonin receptors.

Authors:  A E Voronkov; A A Ivanov; I I Baskin; V A Palyulin; N S Zefirov
Journal:  Dokl Biochem Biophys       Date:  2005 Jul-Aug       Impact factor: 0.788

2.  Fluorine substituted methoxyphenylalkyl amides as potent melatonin receptor agonists.

Authors:  Andrew Tsotinis; Rodanthi Kompogennitaki; Ioannis Papanastasiou; Peter J Garratt; Alina Bocianowska; David Sugden
Journal:  Medchemcomm       Date:  2019-02-11       Impact factor: 3.597

3.  Analogues of diverse structure are unable to differentiate native melatonin receptors in the chicken retina, sheep pars tuberalis and Xenopus melanophores.

Authors:  H Pickering; S Sword; S Vonhoff; R Jones; D Sugden
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

4.  International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors.

Authors:  Margarita L Dubocovich; Philippe Delagrange; Diana N Krause; David Sugden; Daniel P Cardinali; James Olcese
Journal:  Pharmacol Rev       Date:  2010-07-06       Impact factor: 25.468

Review 5.  A molecular and chemical perspective in defining melatonin receptor subtype selectivity.

Authors:  King Hang Chan; Yung Hou Wong
Journal:  Int J Mol Sci       Date:  2013-09-06       Impact factor: 5.923

6.  New quinoxaline derivatives as potential MT₁ and MT₂ receptor ligands.

Authors:  Saioa Ancizu; Nerea Castrillo; Silvia Pérez-Silanes; Ignacio Aldana; Antonio Monge; Philippe Delagrange; Daniel-Henry Caignard; Silvia Galiano
Journal:  Molecules       Date:  2012-06-25       Impact factor: 4.411

Review 7.  Homology models of melatonin receptors: challenges and recent advances.

Authors:  Daniele Pala; Alessio Lodola; Annalida Bedini; Gilberto Spadoni; Silvia Rivara
Journal:  Int J Mol Sci       Date:  2013-04-12       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.